Tag: RedDress

It’s Time to #BreakTheSilence on Diabetic Foot Ulcers

RedDress is launching a nationwide public awareness campaign, “Break the Silence,” educating Americans about the prevalence and prevention methods of diabetic foot ulcers.

Diabetic foot ulcers are sometimes omitted from the national discussion about diabetes and its complications. “Break the Silence” aims to reduce the stigmas associated with diabetic foot ulcers, while promoting and educating Americans about the prevalence and risk factors associated with this complication of diabetes. “Break the Silence” will run through November and coincide with National Diabetes Awareness Month.

Approximately 25 percent of diabetics will suffer a diabetic foot ulcer in their lifetime, according to the Centers for Disease Control and Prevention (CDC). 1,2

“These ulcers are as serious as some cancers. We need to have a national conversation. Right now, we’re looking at diabetes in very broad strokes. I think we have to have a greater dialogue and more information about diabetic foot ulcers, in general,” expressed Dr. Robert Snyder, Dean of Barry University School of Podiatric Medicine in Miami, one of our partner physicians participating in the “Break the Silence ” campaign … read more

RedDress Announces Distribution Agreements in 12 European Countries

Ponte Vedra Beach, Sept. 20, 2021 (GLOBE NEWSWIRE) — RedDress, a privately held U.S. and Israel-based wound care company, announced today strategic agreements in 12 European countries to distribute its innovative CE-marked wound care solution for exuding cutaneous wounds, ActiGraft® system, throughout Europe.

“We are proud to announce our expansion into Europe,” said Alon Kushnir, CEO of RedDress. “Our distribution partnerships in these key areas enable us to deliver our innovative solution in one of the world’s leading wound care markets and will accelerate our growth globally. We are looking forward to providing Europeans with an effective alternative treatment modality as a solution for their hard-to-heal chronic wounds.”

These strategic distribution agreements support RedDress’ global mission to improve the health and lives of patients around the world living with chronic wounds by expanding access to ActiGraft in several European countries:

Austria, Cyprus, Czech Republic, Germany, Greece, Poland, Romania, Slovakia, Slovenia, Switzerland, Turkey, and Ukraine

read more

RedDress Secures Capstone Health Alliance Contract to Expand Access to ActiGraft®

RedDress, a privately held U.S. and Israel-based wound care company, announced today that it has secured a contract with Capstone Health Alliance, one of the nation’s largest regional group purchasing organizations representing 300 hospitals in all 50 U.S. states.

Chronic non-healing wounds impose a significant economic burden on the healthcare system, health care providers, and patients. The ActiGraft® system aims to deliver an affordable and efficacious wound solution to Capstone Health Alliance Members to help improve the health and lives of patients … read more

RedDress Selected to Exhibit ActiGraft at Vizient Innovative Technology Exchange

RedDress has been selected to exhibit ActiGraft®, a wound solution that recreates the natural wound healing environment by utilizing the patient’s own blood, at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest member-driven health care performance improvement company, will hold the Exchange virtually September 21-23, 2021 read more